Evolent Health Statistics

Total Valuation

Evolent Health has a market cap or net worth of $404.13 million. The enterprise value is $1.24 billion.

Market Cap	404.13M
Enterprise Value	1.24B

Important Dates

The next confirmed earnings date is Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

Evolent Health has 111.64 million shares outstanding. The number of shares has decreased by -0.41% in one year.

Current Share Class	111.64M
Shares Outstanding	111.64M
Shares Change (YoY)	-0.41%
Shares Change (QoQ)	-2.15%
Owned by Insiders (%)	1.55%
Owned by Institutions (%)	93.72%
Float	92.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	21.09
PS Ratio	0.22
Forward PS	0.16
PB Ratio	0.97
P/TBV Ratio	n/a
P/FCF Ratio	84.99
P/OCF Ratio	10.40
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.08, with an EV/FCF ratio of 261.19.

EV / Earnings	n/a
EV / Sales	0.66
EV / EBITDA	14.08
EV / EBIT	n/a
EV / FCF	261.19

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 2.38.

Current Ratio	1.31
Quick Ratio	1.20
Debt / Equity	2.38
Debt / EBITDA	10.69
Debt / FCF	208.14
Interest Coverage	-0.08

Financial Efficiency

Return on equity (ROE) is -66.54% and return on invested capital (ROIC) is -0.29%.

Return on Equity (ROE)	-66.54%
Return on Assets (ROA)	-0.12%
Return on Invested Capital (ROIC)	-0.29%
Return on Capital Employed (ROCE)	-0.29%
Weighted Average Cost of Capital (WACC)	5.08%
Revenue Per Employee	$446,721
Profits Per Employee	-$137,953
Employee Count	4,200
Asset Turnover	0.84
Inventory Turnover	n/a

Taxes

Income Tax	-126,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.69% in the last 52 weeks. The beta is 0.37, so Evolent Health's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-59.69%
50-Day Moving Average	2.82
200-Day Moving Average	5.65
Relative Strength Index (RSI)	69.65
Average Volume (20 Days)	2,797,014

Short Selling Information

The latest short interest is 16.20 million, so 14.51% of the outstanding shares have been sold short.

Short Interest	16.20M
Short Previous Month	18.15M
Short % of Shares Out	14.51%
Short % of Float	17.42%
Short Ratio (days to cover)	5.24

Income Statement

In the last 12 months, Evolent Health had revenue of $1.88 billion and -$579.40 million in losses. Loss per share was -$5.07.

Revenue	1.88B
Gross Profit	399.88M
Operating Income	-4.44M
Pretax Income	-534.64M
Net Income	-579.40M
EBITDA	88.22M
EBIT	-4.44M
Loss Per Share	-$5.07

Full Income Statement

Balance Sheet

The company has $151.86 million in cash and $989.70 million in debt, giving a net cash position of -$837.84 million or -$7.50 per share.

Cash & Cash Equivalents	151.86M
Total Debt	989.70M
Net Cash	-837.84M
Net Cash Per Share	-$7.50
Equity (Book Value)	415.19M
Book Value Per Share	3.72
Working Capital	121.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $38.84 million and capital expenditures -$34.09 million, giving a free cash flow of $4.76 million.

Operating Cash Flow	38.84M
Capital Expenditures	-34.09M
Depreciation & Amortization	92.65M
Net Borrowing	65.06M
Free Cash Flow	4.76M
FCF Per Share	$0.04

Full Cash Flow Statement

Margins

Gross margin is 21.31%, with operating and profit margins of -0.24% and -28.49%.

Gross Margin	21.31%
Operating Margin	-0.24%
Pretax Margin	-28.50%
Profit Margin	-28.49%
EBITDA Margin	4.70%
EBIT Margin	-0.24%
FCF Margin	0.25%

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.41%
Shareholder Yield	0.41%
Earnings Yield	-143.37%
FCF Yield	1.18%

Analyst Forecast

The average price target for Evolent Health is $7.93, which is 119.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.93
Price Target Difference	119.06%
Analyst Consensus	Strong Buy
Analyst Count	15
Revenue Growth Forecast (5Y)	19.09%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evolent Health has an Altman Z-Score of 0.49 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.49
Piotroski F-Score	4